NDC 0597-0270-12
Jentadueto XR 2.5 mg/1
linagliptin and metformin hydrochloride · TABLET, FILM COATED, EXTENDED RELEASE
Jentadueto XR is a tablet, film coated, extended release containing linagliptin and metformin hydrochloride at a strength of 2.5 mg/1. Manufactured by Boehringer Ingelheim Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Jentadueto XR
- Generic Name
- linagliptin and metformin hydrochloride
- NDC Code (Package)
0597-0270-12- NDC Code (Product)
0597-0270- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Strength
- 2.5 mg/1
- Dosage Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA208026
- Drug Class
- Dipeptidyl Peptidase 4 Inhibitor [EPC]
- Marketing Start
- 05/27/2016
Recall History
No Recall HistoryView Full Drug Page
Jentadueto XR — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.